Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection

Clinical Infectious Diseases

Volumn 40, Issue SUPPL. 5, 2005, Pages

  Hagan, Holly ^a,b   Strauss, Shiela M ^a   Astone, Janetta M ^a   Des Jarlais, Don C ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; VIRUS ANTIBODY;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL EXAMINATION; METHADONE TREATMENT; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; SCREENING TEST; UNITED STATES;

CROSS-SECTIONAL STUDIES; HEPATITIS C; HUMANS; PHYSICAL EXAMINATION; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 16844374761     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427444     Document Type: Conference Paper

References (21)

1. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159:237-41.
2. Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse 1998; 33:1197-212.
3. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 1994; 16:418-36.
4. van Ameijden EJ, van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993; 9:255-62.
5. McMahon JM, Tortu S. A potential hidden source of hepatitis C infection among noninjecting drug users. J Psychoactive Drugs 2003; 35:455-60.
6. Blattner WA, O'Brien TR, Mueller NE. Retroviruses - human immunodeficiency virus. In: Evans AS, Kaslow RA, eds. Viral infections of humans: epidemiology and control. 4th ed. New York: Plenum Medical, 1997:713-83.
7. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-82.
8. Cherubin CE. The medical sequelae of narcotic addiction. Ann Intern Med 1967; 67:23-33.
9. Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med 1967;67:1-22.
10. Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and non-users. Subst Use Misuse 1999; 34:727-46.
11. Stanley AH. Primary care and addiction treatment: lessons learned from building bridges across traditions. J Addict Dis 1999; 18:65-82.
12. Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit drug users? N Engl J Med 2001; 345:211-5.
13. Westermeyer J, Boedicker AE. Course, severity, and treatment of substance abuse among women versus men. Am J Drug Alcohol Abuse 2000; 26:523-35.
14. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J Health Soc Behav 1999; 40:175-92.
15. Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat 2002; 22:55-62.
16. Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of onsite primary care services by HIV seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep 1993; 108:492-500.
17. Winstock, AR, Sheridan J, Lovell S, Farrell M, Strang J. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis 2000; 19:823-8.
18. Strauss SM, Astone JM, Des Jarlais DC, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend 2004; 73:227-36.
19. Strauss SM, Astone JM, Hagan H, Des Jarlais DC. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health 2004; 81:38-47.
20. Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H. Gaps in the drug-free and methadone treatment program response to hepatitis C. J Subst Abuse Treat 2003; 24:291-7.
21. McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend 2001; 62:9-17.